Switch to:
More From Other Websites
Alkermes Initiates Phase 1 Clinical Trial Of Immuno-Oncology Drug Candidate ALKS 4230 May 25 2016
Alkermes Announces Initiation of Phase 1 Clinical Study of Immuno-Oncology Drug Candidate ALKS 4230 May 25 2016
7:01 am Alkermes initiates a phase 1 clinical study of its immuno-oncology drug candidate, ALKS... May 25 2016
Alkermes Announces Initiation of Phase 1 Clinical Study of Immuno-Oncology Drug Candidate ALKS 4230 May 25 2016
Alkermes Announces Initiation of Phase 1 Clinical Study of Immuno-Oncology Drug Candidate ALKS 4230 May 25 2016
ETF’s with exposure to Alkermes Plc : May 24, 2016 May 24 2016
Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology... May 24 2016
Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology... May 24 2016
Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology... May 24 2016
ALKERMES PLC. Financials May 04 2016
FDA Warns of Rare Impulse Reactions to Abilify Medication May 04 2016
FDA Warns of Rare Reactions to Abilify Medication May 03 2016
Alkermes Plc :ALKS-US: Earnings Analysis: Q1, 2016 By the Numbers May 03 2016
Alkermes (ALKS) Reports Narrower-than-Expected Q1 Loss Apr 29 2016
Edited Transcript of ALKS earnings conference call or presentation 28-Apr-16 12:30pm GMT Apr 28 2016
Alkermes reports 1Q loss Apr 28 2016
Alkermes reports 1Q loss Apr 28 2016
Alkermes Announces Plan to Initiate Second Clinical Trial of ALKS 7119 Based on Preliminary Phase 1... Apr 28 2016
Alkermes plc Reports First Quarter 2016 Financial Results Apr 28 2016
Q1 2016 Alkermes Plc Earnings Release - Before Market Open Apr 28 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK